---
artifact:
  type: product-owner-signoff
  from: Product Owner
  to: MOD-W Moderator
  date: 2026-10-04
  review_artifacts:
    - prod-w/representation-options.md
    - mod-w/step-05.md
    - mod-w/reviews/TECH-LEAD-REVIEW-STEP-05.md
    - mod-w/reviews/MODERATOR-REVIEW-STEP-05-TECH-LEAD.md
    - mod-w/reviews/QA-REVIEW-STEP-05.md
    - mod-w/reviews/MODERATOR-REVIEW-STEP-05-QA.md
    - mod-w/reviews/TECH-LEAD-REVIEW-STEP-05-QA-DIRECTION.md
    - research/mod-w-transferability/observations.md#MW-OBS-017
  review_status: SIGNED_OFF_WITH_CONDITIONS
---

# Product Owner Sign-off: STEP-05 (Phase 3c)

**Reviewer role:** Product Owner  
**Date:** 2026-10-04  
**Review target:** `prod-w/representation-options.md` v0.1, Draft  
**Standing:** Product Owner sign-off for v0.1 only. This is not final Moderator acceptance. No review is waived.

---

## 0. Standing of this document

- This sign-off covers **v0.1 as it stands**. If `prod-w/representation-options.md` is corrected later, Product Owner sign-off needs re-confirmation.
- I did not edit `prod-w/representation-options.md`, any accepted product artifact, any review record, or the research register.
- The Tech Lead and QA reviews are complete for v0.1, and the Moderator's 2026-10-04 Addendum sends v0.1 to Product Owner with QAS5-01 to QAS5-07 carried as named soft spots.
- Final Moderator acceptance is pending and is not recorded here.
- I am not a Claude-family model. The producing Development Team, Tech Lead review, and QA review identify Claude-family involvement. Under PR-27 and PR-28, that same-vendor review chain is not independent corroboration.

---

## 1. Sign-off status

**SIGNED OFF WITH CONDITIONS.**

The memo gives me what STEP-05 promised at the product-decision level: a fair enough comparison of the nine representation families, an explicit statement that no family carries the semantics alone, no final representation selection, and an actionable recommendation that the Moderator can either authorize later or decline without disturbing the rest of the memo.

I accept v0.1 as a STEP-05 evaluation memo with the carried QA soft spots visible. I do **not** accept every sentence as final wording for later semantic disposition.

### Conditions

| ID | Condition |
| --- | --- |
| PO5-C1 | Moderator must not dispose RQ-01 by accepting the QA5-03 basis-presentation definition **as worded** in v0.1. The shape of the answer is right, but QAS5-03 must be corrected or explicitly constrained before RQ-01 is accepted. |
| PO5-C2 | Any later correction to v0.1 requires Product Owner re-confirmation before final acceptance of the corrected artifact. |
| PO5-C3 | Final acceptance should carry the QAS5-01 to QAS5-07 soft spots explicitly if no correction pass is made. They are not hidden by this sign-off. |

---

## 2. Product Owner answers

### 2.1 Does the memo give STEP-05 what it promised?

**Yes, with the soft spots carried.**

The memo compares the nine required families, keeps protocol/schema/state separation visible, identifies what each option cannot carry alone, rejects premature final selection, and routes open questions rather than using a representation to make them disappear.

The QA findings weaken reproducibility of some tables and demand-class mappings. They do not change the product-level conclusion that no representation family should be selected now and that any later experiment must remain severable.

### 2.2 Is RX-1 acceptable as later, optional work?

**Yes.**

I accept RX-1 as an optional later probe, not a decision. Section 14 keeps it narrow, comparative, throwaway, and dependent on Moderator authorization. If the Moderator does not authorize RX-1 or does not decide where it sits, the fallback of prerequisites before experimentation is acceptable.

I do not decide RX-1 placement or authorization. That remains the Moderator's call.

### 2.3 QA5-03 / Section 10.2

**I accept the shape of the answer, not the v0.1 wording.**

A recorded basis-presentation designation is the right kind of representation-layer answer: it makes the disputed element recorded and attributable instead of inferred from evidence links. That is what I want product users and evaluators to rely on.

I do **not** endorse Section 10.2 Property 3 as worded. QAS5-03 is material to sign-off because a citation must not itself count as the QA5-03 designation. RQ-01 and RQ-02 remain undecided.

### 2.4 F-5 actor-kind authentication

**Yes.**

Section 9.5 matches my product intent: a representation can carry a recorded kind designation and provenance about binding methods, but no representation, schema, record, or signature proves that a human acted. Publication and conformance wording must preserve that limit.

### 2.5 Routed questions

I accept the RQ-01 to RQ-18 routing as fit for v0.1, subject to the QA5-03 condition above.

I want **RQ-19 changed** if the artifact is revised: "Deferred" should name an owner or disposition path. My preferred routing is **later architecture and MOD-W Moderator disposition**, with STEP-08 only for research-synthesis implications if needed. External evaluator contract, agent-harness conformance, and transport/interchange should not remain ownerless.

---

## 3. Soft-spot disposition

| Finding | Product Owner position |
| --- | --- |
| QAS5-01 | **Accept as carried.** It affects confidence in entry-by-entry reproducibility, not the product conclusion. If revised, make the family-level nature of the mapping explicit and add the omitted visibility and producer-set demands. |
| QAS5-02 | **Accept as carried.** It affects sign-off because it can make recorded-kind checks look impossible. I still accept Section 9.5's product position. If revised, split recorded designation from attribution truth/human-presence assurance. |
| QAS5-03 | **Want corrected before RQ-01 disposition.** This is the one soft spot I do not want carried into a Moderator acceptance of the QA5-03 definition. Citation alone must not be a designation. |
| QAS5-04 | **Accept as carried.** Comparison-table label inconsistencies are low-risk because the memo is not scored or ranked. Correct them if a text pass happens. |
| QAS5-05 | **Accept as carried.** The fuller table controls over the summary bullets. Correct if a text pass happens. |
| QAS5-06 | **Accept as carried.** The thinner hybrid and RO-09 treatment does not change my acceptance of the no-selection conclusion or RX-1 as optional later work. |
| QAS5-07 | **Accept as carried.** The omitted STEP-04 items are owned elsewhere. A one-line non-ownership note would be useful but is not required for Product Owner sign-off on v0.1. |

---

## 4. Items for the Moderator

1. Do not record final acceptance until this Phase 3c record is reviewed along with the completed Phase 3a and 3b records.
2. Decide whether v0.1 is accepted with QAS5-01 to QAS5-07 carried, or whether a correction pass is required first.
3. Do not accept RQ-01's QA5-03 definition as worded; require the QAS5-03 constraint or correction first.
4. Decide RX-1 authorization and placement, if any. Product Owner accepts it only as later optional work.
5. Decide MW-OBS-017 disposition. It remains proposed and non-blocking.
6. Preserve the same-vendor review limit in final acceptance. Tech Lead and QA review are valid governance records, but not independent corroboration under PR-27 and PR-28.
7. If revised, route RQ-19 to a named owner/path rather than leaving it as only "Deferred."

---

## 5. Not done and not recorded

- No final Moderator acceptance is recorded.
- No review is waived.
- RQ-01 and RQ-02 are not decided.
- RX-1 is not authorized.
- No representation, schema, store, validator, lifecycle graph, state vocabulary, prompt format, agent harness, runtime integration, transport, database, API, or publication package is selected.

MOD-W v5.0.1
